PRVL
Prevail Therapeutics Inc. Common Stock
PRVL
PRVL
Delisted
PRVL was delisted on the 21st of January, 2021.
46 hedge funds and large institutions have $427M invested in Prevail Therapeutics Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
46
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$5.8M | |
| 2 | +$4.23M | |
| 3 | +$1.58M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.22M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.13M |
Top Sellers
| 1 | -$18.2M | |
| 2 | -$2.28M | |
| 3 | -$1.25M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.11M |
| 5 |
Millennium Management
New York
|
-$618K |